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Abstract
Background: Bedside tests for C-reactive protein
(CRP) have been studied in pediatric patients, but not
in neonates.
Methods: This study compared the results of two
rapid bedside tests for CRP (Quick-Read CRP, Orion
Diagnostic, Espoo, Finland and NycoCard CRP-Single
Test, Axis-Shield, Oslo, Norway) with those of our
central laboratory method (CRP-Lab) in newborn
infants. CRP concentrations were determined using 72
samples obtained from 43 infants with suspected sep-
sis occurring between 1 and 28 days of life.
Results: Considering positive CRP concentrations to
be G10 mg/L, both bedside tests had good specificity
(Quick-Read 80.5%, NycoCard 83.3%) and sensitivity
(Quick-Read 97.2%, NycoCard 94.4%) when compared
with our CRP-Lab. The agreement of measurement
with central laboratory values was high for both the
bedside tests, without statistically significant differ-
ences between the methods. The Quick-Read and
NycoCard methods did not show any statistically sig-
nificant systematic proportional bias when compared
with the central laboratory values. The accuracy of the
results of both bedside tests is somewhat decreased
when CRP concentrations are )100 mg/L.
Conclusions: This study shows that both the Quick-
Read and the NycoCard test can be used for serial
determinations of CRP concentrations in newborn
infants. They require small volumes of blood and
provide reliable results in -5 min.
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Introduction
Neonatal sepsis is a systemic disease, characterized
by massive microbial invasion followed by a systemic
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inflammatory response (1–3). It affects 15%–30% of
newborn infants admitted to the neonatal intensive
care unit, particularly very low birth weight infants,
with high mortality (2). Because the suspicion of
sepsis in the neonate is often based on non-specific
clinical signs, several predictive laboratory parame-
ters have been investigated, including white blood
cell count, tumor necrosis factor, interleukin-6, serum
amyloid A, procalcitonin and C-reactive protein (CRP)
(4–8). Serial CRP measurements are also used to
monitor the evolution of bacterial diseases because
CRP concentration drops quickly in response to effec-
tive treatment (9). Monitoring CRP concentration can
lead to shorter antibiotic regimens or, alternatively,
can alert one to the likelihood of complications and
help predict outcome, even earlier than clinical signs
(10). Conventional laboratory methods for CRP can be
unavailable in urgent situations, or may not provide
results in a timely manner. They usually require at
least 1 mL of blood and are uncomfortable if used for
serial measurements in newborn infants. Rapid bed-
side quantitative assays for CRP that require insigni-
ficant amount of blood have been developed recently.
Unfortunately, no data has been published about their
use in the neonatal period, apart from the short report
by Makhoul and coworkers on late-onset sepsis (11).
The aim of this study was to compare the diagnostic
accuracy between two rapid bedside tests for CRP
compared with the laboratory method, and provide
information about their reliability in newborn infants.
Materials and methods
Study population
This prospective observational study was conducted from
March to September 2008, in the Division of Neonatology at
our University Hospital. The study was approved by our
Institutional Ethical Board. We included all newborns who
developed clinically suspected sepsis during the first month
of life. Infants were confined to open cots or incubators,
depending on their weight. For each infant we collected
gestational age, birth weight, age and weight when sepsis
was first suspected, hematocrit and CRP values. Work-up for
sepsis included blood, urine and cerebrospinal fluid cultures
for all infants. Culture of bronchoalveolar lavage fluid was
also performed in infants that were ventilated.
Laboratory methods
A 1 mL blood sample was drawn from the peripheral vein
for CRP measurements. CRP was measured on the same
sample, using our central laboratory method (CRP-Lab) and
two different bedside tests, each requiring ;3 min to obtain
the result. Our central laboratory measures CRP by the
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Figure 1 Passing-Bablok regression analysis between the central laboratory method and the two bedside tests.
The analysis includes 36 samples with CRP-Lab concentrations G10 mg/L. CRP values expressed as mg/L. The solid and
dashed lines indicate the regression line and confidence interval for the regression line, respectively. CRP-Lab, central labo-
ratory method; CRP-Q, Quick-Read test; CRP-N, NycoCard test.
Table 1 Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) for the two bedside tests,
assessed in comparison with central laboratory CRP concentrations G10 mg/L.
Sensitivity, % Specificity, % PPV, % NPV, %
Quick-Read CRP 97.2 80.6 83.3 96.7
NycoCard CRP single test 94.4 83.3 85.0 93.8
CardioPhase hsCRP on BN II System (Dade Behring, Newark,
NJ, USA) which is a particle enhanced immunoturbidimetric
method requiring 1 mL of whole blood. Due to organizational
considerations, our central laboratory gives us the result in
;24 h, even though this method requires only 6 min to per-
form. The result is evaluated by comparison to a standard
with a known CRP concentration. The assigned value of CRP
in N Rheumatology Standard SL is traceable to the interna-
tional reference preparation BCR-CRM 470 (12). The lower
limit of detection for CRP for our laboratory is 0.175 mg/L.
The Quick-Read CRP (CRP-Q; Orion Diagnostic, Espoo, Fin-
land) is an immunoturbidometric assay based on micropar-
ticles coated with anti-human CRP. This method measures
the change in turbidity of the solution caused by the reaction
of the particles and CRP in the sample. It requires 20 mL of
whole blood and provides results in 2 min, with an analytical
measurement range of 8–160 mg/L. The NycoCard CRP-sin-
gle test (CRP-N; Axis-Shield, Oslo, Norway) is a solid phase,
sandwich-format, immunometric assay requiring only 5 mL
of whole blood. In the test well of the device a membrane is
coated with immobilized CRP-specific monoclonal antibod-
ies. When the sample flows through the membrane, CRP is
captured by the antibodies in a sandwich-type reaction. The
membrane changes color in the presence of pathological
concentrations of CRP. The instrument quantitatively meas-
ures the color intensity in 3 min with an analytical measure-
ment range of 8–200 mg/L. As recommended by the
manufacturer, all results obtained with the two bedside
assays were corrected for hematocrit values that deviated
from 40%, using a fixed table provided by the manufacturer.
A coefficient of variation of 7% was observed at a CRP con-
centration of 0.41 mg/L for the CRP-Lab, and at a CRP con-
centration of12 mg/L for the bedside tests.
Statistics
Sensitivity, specificity, positive and negative predictive
values were calculated comparing all the measurements
obtained by the bedside tests (CRP-Q Quick-Read test; CRP-
N NycoCard test) with those performed in the CRP-Lab. CRP
values G10 mg/L were considered as positive for all three
tests. Considering only positive CRP values, we evaluated
the agreement of measurements between each bedside test
and the central laboratory test using Passing-Bablok non-
parametric regression. The regression equation was
expressed with the 95% confidence interval (CI) for the esti-
mates of the slope and intercept. The Bland-Altman plot was
chosen to visualize the agreement between each bedside
test and the CRP-Lab. We performed univariate linear regres-
sion to verify the possible influence of some factors on the
difference between each of the methods investigated and the
CRP-Lab. Variables included in the model were gestational
age, birth weight, age and weight when sepsis was suspect-
ed, hematocrit and CRP values. The coefficient of determi-
nation (r2) was used to check for the goodness of fit. Only
those variables with a p-0.25 were considered for multiple
linear regression analysis. Statistical analyses were per-
formed with Microsoft Excel 2003, SPSS for Windows rel.
17.0 (SPSS, Inc., Chicago, IL, USA) and Medcalc software rel.
9.3.7.0 (Medcalc, Mariakerke, Belgium). A p-0.05 was con-
sidered for statistical significance.
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Figure 2 Bland-Altman plots between the CRP-Lab method
and the two bedside tests.
The analysis includes 36 samples with CRP-Lab concentra-
tions G10 mg/L. CRP values expressed as mg/L. CRP-Lab,
central laboratory method; CRP-Q, Quick-Read test; CRP-N,
NycoCard test.
Results
A total of 72 blood samples were obtained for mea-
surement of CRP concentrations. These samples were
collected from 43 infants during 52 episodes of work-
up of suspected sepsis performed between 1 and
28 days of life (median 11, interquartile range
5–22 days). Gestational age and birth weight of the
43 infants were 33"5 weeks (range 25–41 weeks)
and 2250"950 g (range 510–4180 g).
In the 36 samples with CRP-Lab concentrations
G10 mg/L only one had CRP-Q -10 mg/L and two had
CRP-N -10 mg/L. In the 36 samples with CRP-Lab
levels -10 mg/L, seven had a CRP-Q )10 mg/L and
six had a CRP-N )10 mg/L. The specificity, sensitivity
and predictive values are shown in Table 1.
Passing-Bablok regression yielded an equation of
ys1.0734xq1.8110 for CRP-Q and ys0.8759xq
0.9522 for CRP-N (see Figure 1). The slope and the
intercept were not significantly different from 1 and
0, respectively. The Cusum test confirmed no signifi-
cant deviation from linearity (p)0.10). Bias for both
assays vs. CRP-Lab was evaluated using Bland-Alt-
man plots and is shown in Figure 2. The average bias
values were determined to be 5.8 mg/L (95% CI –19
to 13.4) for CRP-Q and –5.7 mg/L (95% CI –12.6 to 1.2)
for CRP-N. This means that Quick-Read and NycoCard
had no statistically significant systematic proportional
bias. The Bland-Altman plots also showed that the
reliability of both bedside tests decreased with
increases in CRP-Lab values. Univariate linear regres-
sion confirmed that the difference between each of
the methods investigated and the CRP-Lab is affected
by the highest CRP-Lab values only, and this was a
bit more evident for CRP-N (r2s0.4693) than for CRP-
Q (r2s0.3052). We did not perform multivariate
regression analysis because no other variables
reached p-0.25 in the univariate analysis.
Discussion
Sepsis remains one of the main causes of neonatal
morbidity and mortality and is particularly true for
very low birth weight infants (13, 14). In the study
published by Stoll and coworkers in 2002, of 6215
very low birth infants who survived beyond 3 days,
21% had one or more episodes of sepsis with a mor-
tality rate of 18% (14). Antimicrobial treatment is often
started on the basis of non-specific clinical signs
because an early diagnosis can be crucial to optimize
patient outcome. This attitude implies a widespread
tendency for antibiotic abuse with the consequent risk
of antimicrobial resistance. Between the several lab-
oratory parameters that are predictive of sepsis, CRP
has been thoroughly investigated because it can be
detected within 6–12 h following the onset of the
inflammatory process, and it peaks more quickly than
other acute phase reactants (15, 16). However, the
amount of blood and the time to obtain results from
the central laboratory can constitute important limi-
tations to serial CRP measurements in neonates with
suspected sepsis. Despite the development of rapid
quantitative bedside assays for CRP requiring an
insignificant amount of blood, the short report by
Makhoul and coworkers on late-onset sepsis is the
only one published about their use in the neonatal
period (11). Some authors studied the usefulness of
CRP determinations in neonatal sepsis, but they did
not use bedside tests (4, 8, 17, 18). Others studied
bedside tests in pediatric patients, but not in neonates
(19–22). For these reasons, we designed this prospec-
tive study to compare the diagnostic accuracy
between two rapid bedside tests for CRP compared
with a laboratory method and to provide information
concerning their reliability in newborn infants.
Considering CRP values G10 mg/L to be positive,
both bedside tests have good specificity (Quick-Read
80.5%, NycoCard 83.3%), and an even better sensi-
tivity (Quick-Read 97.2%, NycoCard 94.4%), when
compared with our CRP-Lab. The agreement of meas-
urement with the central laboratory values as esti-
mated by Passing-Bablok analysis is high for both the
bedside tests, without significant differences between
them. The slope was 1.0734 for Quick-Read and
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0.8759 for NycoCard. Both Passing-Bablok regression
and Bland-Altman analysis showed that Quick-Read
and NycoCard have no statistically significant system-
atic proportional bias. Univariate regression analysis
showed that gestational age, birth weight, hematocrit
and day of life have no influence on the agreement of
measurement between the bedside tests and the cen-
tral laboratory assay. The accuracy of measurements
for both the bedside tests is affected only by very high
CRP concentrations ()100 mg/L). This finding was
more evident for the NycoCard than for the Quick-
Read test. Interestingly, this observation is in agree-
ment with that of Cohen et al. (20) who found relevant
quantitative discrepancies between the CRP-N and
their CRP-Lab for CRP concentrations )150 mg/L.
However, this limitation is of little clinical relevance
considering that only four out of 72 of our study sam-
ples showed CRP concentrations )100 mg/L.
In conclusion, we provide evidence that both the
Quick-Read test and the NycoCard test have excellent
correlation with a validated CRP assay in newborn
infants. They have high sensitivity and specificity,
require a very small amount of blood, and are easy
to use at the bedside of the patient. Also, they provide
highly reliable results in -5 min. These characteris-
tics allow them to be used for serial determinations
of CRP concentrations in newborn infants, and can be
of great help for clinicians for diagnosing and man-
aging neonatal sepsis.
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